| __timestamp | Exelixis, Inc. | Walgreens Boots Alliance, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 50829000 | 17992000000 |
| Thursday, January 1, 2015 | 57305000 | 22400000000 |
| Friday, January 1, 2016 | 116145000 | 23910000000 |
| Sunday, January 1, 2017 | 159362000 | 23813000000 |
| Monday, January 1, 2018 | 206366000 | 24694000000 |
| Tuesday, January 1, 2019 | 228244000 | 23557000000 |
| Wednesday, January 1, 2020 | 293355000 | 25436000000 |
| Friday, January 1, 2021 | 401715000 | 24586000000 |
| Saturday, January 1, 2022 | 459856000 | 27295000000 |
| Sunday, January 1, 2023 | 542705000 | 34205000000 |
| Monday, January 1, 2024 | 492128000 | 28113000000 |
Unleashing insights
In the ever-evolving landscape of corporate finance, understanding cost management is crucial. Walgreens Boots Alliance, Inc. and Exelixis, Inc. offer a fascinating study in contrasts. Over the past decade, Walgreens has consistently managed its Selling, General, and Administrative (SG&A) expenses, maintaining a steady increase of around 44% from 2014 to 2023. This reflects their strategic expansion and operational efficiency. Meanwhile, Exelixis, a smaller player, has seen its SG&A expenses skyrocket by over 900% in the same period, indicative of its aggressive growth strategy and investment in innovation.
The data reveals a missing value for Exelixis in 2024, suggesting potential volatility or strategic shifts. As businesses navigate the complexities of cost management, these insights underscore the importance of balancing growth with financial prudence.
Selling, General, and Administrative Costs: Novartis AG vs Walgreens Boots Alliance, Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Ascendis Pharma A/S
Walgreens Boots Alliance, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Walgreens Boots Alliance, Inc. and Catalyst Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: Walgreens Boots Alliance, Inc. vs Alkermes plc
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Veracyte, Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Perrigo Company plc
Cost Management Insights: SG&A Expenses for Exelixis, Inc. and Opthea Limited
Exelixis, Inc. and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Exelixis, Inc. or Iovance Biotherapeutics, Inc.
Selling, General, and Administrative Costs: Exelixis, Inc. vs BioCryst Pharmaceuticals, Inc.